The Acute Effect of Interval-walking
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Type 2 Diabetes Mellitus
Related studies linked through entity extraction aliases.
Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
- Status
- COMPLETED
- Phase
- PHASE3
Fasiglifam 25 mg BID vs 50 mg QD
- Status
- TERMINATED
- Phase
- PHASE2
A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- N/A
Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients
- Status
- COMPLETED
- Phase
- NA
Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Impact of Web-based Care Management for Poorly Controlled Type 2 Diabetes Mellitus: a Randomized, Controlled Trial
- Status
- WITHDRAWN
- Phase
- NA
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)
- Status
- COMPLETED
- Phase
- PHASE3
Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Exenatide on Liver and Heart Fat and Inflammation
- Status
- COMPLETED
- Phase
- PHASE4
A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
- Status
- COMPLETED
- Phase
- PHASE1
Ready to Act - Health Education in People With Hyperglycaemia
- Status
- COMPLETED
- Phase
- NA
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test
- Status
- COMPLETED
- Phase
- PHASE2